Betamethasone (Lenovate, Betanoid, Steromien /Stroop, Betanoid Co, Betnesol Eye Ear And Nose, Betnesol Eye, Persivate, Lenasone)
Betamethasone
Pharmacare limited û woodmead
Registration
- Applicant
- Pharmacare limited û woodmead
- Registrations
- 12
- Schedule source
- SAHPRA documentation
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Lenovate ointment EACH 5 G OINTMENT CONTAINS BETAMETHASONE VALERATE EQUIVALENT TO 5 MG BETAMETHASONE | Ointment | 27030827/13.4.1/0308 | Registered | Not determined | None |
| Betanoid syrup EACH 5 ml SYRUP CONTAINS BETAMETHASONE 0,6 mg | 0,60 mg /5 mlSyrup | 27049127/21.5.1/0491Approved 4 April 2024 | Registered | S4 | PIPIL |
| Lenovate cream EACH 5 g CREAM CONTAINS BETAMETHASONE VALERATE EQUIVALENT TO 5 mg BETAMETHASONE | Cream | 27049327/13.4.1/0493 | Registered | Not determined | None |
| Betanoid tablets EACH TABLET CONTAINS BETAMETHASONE 0,5 mg | 0,5 mgTablets | 27054327/21.5.1/0543Approved 26 November 2024 | Registered | S4 | PIPIL |
| Betanoid injection 4 mg/ml EACH 1 ml LIQUID CONTAINS BETAMETHASONE SODIUM PHOSPHATE EQUIVALENT TO 4,0 mg BETAMETHASONE | 4 mg/mlInjection | 30032430/21.5.1/0324 | Registered | Not determined | None |
| Steromien syrup/stroop EACH 5 ml SYRUP CONTAINS BETAMETHASONE 0,60 mg | Syrup/stroop | 31054831/21.5.1/0548 | Cancelled | Not determined | None |
| Betanoid co EACH 1,0 ML CONTAINS: BETAMETHASONE SODIUM PHOSPHATE EQUIVALENT TO BETAMETHASONE (IN SOLUTION) 3,0 mg BETAMETHASONE ACETATE ( IN SUSPENSION) 3,0 mg | Not listed | 50043150/21.5.1/0431 | Registered | S4 | None |
| Betnesol eye , ear and nose drops EACH 100 ml CONTAINS BETAMETHASONE SODIUM PHOSPHATE A 100,0 mg | ,Drops | H1257 | Old Medicine | S4 | None |
| Betnesol eye ointment EACH 100 g CONTAINS BETAMETHASONE SODIUM PHOSPHATE A 0,1 g | Ointment | H1259 | Old Medicine | S4 | None |
| Persivate EACH 5 G CREAM CONTAINS BETAMETHASONE VALERATE EQUIVALENT TO 5 MG BETAMETHASONE | Not listed | L0382L/13.4.1/382 | Registered | Not determined | None |
| Persivate ointment EACH 5 G OINTMENT CONTAINS BETAMETHASONE VALERATE EQUIVALENT TO BETAMETHASONE 5 MG | 5 mg/5 gCream, ointment | L0395L/13.4.1/395Approved 1 May 2024 | Registered | S4 | PIPIL |
| Lenasone injection 4 mg/ml EACH 1 ml AMPOULE CONTAINS BETAMETHASONE SODIUM PHOSPHATE EQUIVALENT TO BETAMETHASONE 4 mg | 4 mg/mlInjection | X0361X/21.5.1/361 | Registered | Not determined | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Betamethasone
S4: Betamethasone
Consolidated Schedules 06 July 2026, line 5481
S3: Calcipotriol
Consolidated Schedules 06 July 2026, line 3258
Pharmacological class: Corticosteroids and analogues. (class 21.5.1)
Matched through the component Calcipotriol.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(8S,9R,10S,11S,13S,14S,16S,17R)-9-Fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
Drag to rotate. Structure from PubChem CID 9782.
SAHPRA documents
Schedule Verification
This medication's schedule (S4) has been verified from official SAHPRA documents with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.